MIRA
INFORM REPORT
|
Report Date : |
02.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
KOPRAN (HK) LTD |
|
|
|
|
Registered Office : |
Rm 328 Peninsula Centre 67 Mody Rd, Tsimshatsui East
Kowloon |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
July 12, 1994 |
|
|
|
|
Com. Reg. No.: |
0485067 |
|
|
|
|
Legal Form : |
Private |
|
|
|
|
Line of Business : |
Import and trading of medicines and other related pharmaceutical
products. Distribution and sale of products to local market. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Maximum Credit Limit : |
Up To USD 15,000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
name & address
KOPRAN (HK) LTD
RM 328 PENINSULA CENTRE 67 MODY RD
TSIMSHATSUI EAST KOWLOON, HONG KONG.
TEL: 852-27212519
FAX: 852-27235542
EXECUTIVE SUMMARY
INCORPORATION DATE :
JULY 12, 1994
REGISTRATION NO. :
0485067
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
N/A
STAFF STRENGTH :
10
CAPITAL :
US$ 320,924
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
FAIR
RECOMM. CREDIT RANGE : UP TO
USD 15,000
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.75406 = US$1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M – million
HKD –Hong Kong Dollars
*Company Registration*
===================
(1)
License number : 0485067
Date issued : 12 July,
1994
Issuing authority : Companies
Registry
Legal form : Private Company Having a Share Capital
Type of license : Corporate
(2)
License number : 18490475-000
Date issued : N/A
Issuing authority : Business
Registration Office - Inland Revenue Dept
Type of license :
Business
*Capital Details*
=============
Share value : HKD
1.00/-each
Authorized capital : HKD
2,500,000.00
Paid-up capital : HKD
2,318,750.00 divided into 2,318,750 ordinary shares
*Office & Facilities*
===============
Other Contact Details
--------------------------
Tel no. : 27235541
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
SC is not known to host website of its own at present.
For the past two years there is no record of litigation.
*Major Shareholders*
================
Total number of shareholders
: 3
Total number of ordinary shares : 2,318,750
Shareholders' Name
No. of Ordinary Shares Amount
of Shares (HKD) % of Shares
------------------ ------------------------------- ---------------------------------- ----------------
KOPRAN CO LTD 2,318,748
2,318,748.00 100.00
Mr. Hanuman Prasad Vyas 1 1.00 0.00
Mr. Surajratan Peety 1
1.00 0.00
*Directors' Details*
===============
(1)
Mr. Chandramohan Balkishan Singhi
India passport number : A0711585
Address
: 11/161 Kamal Park Veer Savarkar Marg Mumbai (Bombay) Maharashtra
400016 India
(2)
Mr. Hanuman Prasad Vyas
India passport number : S982852
Address
: Rm 328 Peninsula Centre 67 Mody Rd Tsimshatsui East Kowloon Hong Kong
Shareholder's Details
-----------------------------
Mr. Surajratan Peety
Address
: Rm 328 Peninsula Centre 67 Mody Rd Tsimshatsui East Kowloon Hong Kong
*Company Secretary*
=================
Corporate Secretary
--------------------------
TAXBASE CONSULTANTS LTD
Address : Rm 615, 6Fl Hollywood Plaza 610 Nathan Rd Kowloon Hong
Kong
SC’s management background details are not available at present.
*Main Products & Services*
=====================
Specializes in the following areas of work :
1. Import and trading of medicines and other related pharmaceutical
products.
2. Distribution and sale of products to local market.
Products: Amoxicillin
Ampicilin
Antibiotics
Bulk drugs
Pharmaceutical
ingredients
*Payment Terms*
==============
Sales
-------
Local : Cash or credit
Purchases
--------------
Local : Cash or credit
Import : Letter of Credit (L/C)
*Local Distribution Network*
=======================
100% of the annual turnover is attributed to local sales.
*Export Markets*
==============
There is no record of export since the prime focus of the firm's
activity is concentrated on local sales only.
SC is not known to have any subsidiary at
present.
PAYMENT RATING : 4 OBTAINED SCORES : 48
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment
pattern of SC based upon our Payment Database, comments from suppliers of SC,
information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL amounts
depending on individual judgement experience.
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financials.
*Bank Details*
===========
Bank : HONG KONG & SHANGHAI
BANKING CORP LTD, THE
Branch : Ground Fl Peninsula
Centre TST Kowloon
Swiftcode : HSBCHKHH
SC is considered small-sized in its line with a 13 years development
history. Taking into consideration of SC’s general performance, a credit line
up to USD 15,000 would appear to be within SC’s capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2834 Pharmaceutical
preparations
Trading 5122 Drugs/Druggists'
Sundries
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2941 Antibiotics
Trading 2941101000 Ampicillin
and its salts
Trading 2941906000 Antibiotics
Trading 3000 Pharmaceutical
products
Trading 3003 Medicaments
of mixtures, not dosage etc form
Trading 3004 Medicaments,
mixed or not, in dosage etc form
Trading 3004906090 Medicaments
not elsewhere specified or included
DETAILED PRODUCT
CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Trader Pharmaceutical
products
INTERNATIONAL
TRADE : ACTIVITY & MARKETS
Importing from Asia
Importing from India
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)